PharmAthene (PIP) Shares Jump Amid Mid-Day Upgrade from Rodman & Renshaw

Shares of PharmAthene (NYSE: PIP) are on the move in afternoon trade Wednesday following an intraday upgrade from Rodman & Renshaw's Elemer Piros.

Despite the upgrade, shares are still down nearly 5 percent from Tuesday's close.

The analyst now rates PharmAthene shares a Market Perform, up from Market Underperform previously.

For more ratings news on PharmAthene click here and for the rating history of PharmAthene click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• B.Riley Upgrades RF Industries Ltd. (RFIL) to Buy
• Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
• Bloom Burton & Co. Upgrades Aurinia Pharmaceuticals (AUPH) to Buy (1)